AWM
ANIK icon

Avior Wealth Management’s Anika Therapeutics ANIK Stock Holding History

Avior Wealth Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$76 – 2331
2024
Q1 		$76 Buy
+3
New +$73 ﹤0.01% 3303
2022
Q2 		– Sell
-9,436
Closed -$211K – 1055
2022
Q1 		$236K Sell
9,436
-1,872
-17% -$57.1K 0.02% 412
2021
Q4 		$405K Hold
11,308
– – 0.03% 356
2021
Q3 		$481K Hold
11,308
– – 0.04% 323
2021
Q2 		$489K Sell
11,308
-2,028
-15% -$86.4K 0.05% 302
2021
Q1 		$543K Buy
13,336
+252
+2% +$9.56K 0.06% 281
2020
Q4 		$592K Hold
13,084
– – 0.07% 228
2020
Q3 		$463K Buy
13,084
+1,855
+17% +$67K 0.07% 247
2020
Q2 		$423K Hold
11,229
– – 0.07% 263
2020
Q1 		$324K Hold
11,229
– – 0.06% 261
2019
Q4 		$582K Hold
11,229
– – 0.09% 210
2019
Q3 		$616K Sell
11,229
-2,077
-16% -$107K 0.11% 182
2019
Q2 		$540K Hold
13,306
– – 0.1% 195
2019
Q1 		$402K Buy
13,306
+3,731
+39% +$128K 0.09% 236
2018
Q4 		$321K Hold
9,575
– – 0.08% 236
2018
Q3 		$404K Hold
9,575
– – 0.09% 216
2018
Q2 		$306K Buy
9,575
+1,000
+12% +$41.2K 0.07% 245
2018
Q1 		$426K Hold
8,575
– – 0.1% 187
2017
Q4 		$462K Buy
+8,575
New +$475K 0.1% 185

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avior Wealth Management's ANIK Position: Q2 2024 in Review

Avior Wealth Management sold out of Anika Therapeutics (ANIK) in Q2 2024, closing a stake of 3 shares — an estimated $76 sold.

Avior Wealth Management first reported a position in ANIK in Q4 2017 and held it in 19 quarters. The position peaked at $616K in Q3 2019. 114 funds tracked by Wall St. Rank hold ANIK as of Q2 2024.

  • Avior Wealth Management reported no remaining Anika Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 3 Anika Therapeutics shares in Q2 2024, an estimated $76.
  • Avior Wealth Management first reported a position in Anika Therapeutics in Q4 2017 and held it in 19 quarters.
  • Avior Wealth Management's Anika Therapeutics position peaked at $616K in Q3 2019.
  • 114 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.